Biopharmaceutical Processing - Sligo

This programme has been designed to meet the existing and projected needs of the sector and will help produce confident graduates that are technically competent for employment in this industry.

Subjects taught


Legislation and Reg. Affairs
Fermentation and Cell Culture
Elective: Upstream Processing OR Scale Up and Tech Transfer
Protein Purification
Research Methods
Elective: Downstream
Processing OR Formulation and Delivery Systems
Bioprocessing Thesis

Entry requirements

This programme is open to students who have obtained an honours degree (Level 8), or its equivalent, in an appropriate discipline (i.e. Engineering or Life Sciences). Other candidates with alternative honours degrees and relevant experience in the BioProcessing industry (typically 5 years duration in a GMP environment) may apply for consideration through the ATU Sligo RPL (Recognised Prior Learning) process. These candidates will be interviewed for suitability and be subject to prior approval by the Programme Board.

Who should apply?
Those already working in the biomanufacturing industry who may wish to advance their career in the sector.

Application dates

Applications for online programmes are accepted on the atu sligo website.

All programmes advertised will run subject to sufficient student numbers.

ATU sligo online has two intakes per year, the main one being in September with a smaller listing of programmes for January. For confirmation on start dates check

For September, applications open from 1st February each year. Closing date for receipt of applications is 31st august.

For January, applications open from 1st November each year. Closing date for applications is mid-January.

The online application form requires personal details, previous qualifications, professional accreditations, employment history and a personal statement. We recommend collating all the necessary paperwork i.e. Transcripts of previous qualifications, academic certificates before you submit an application.

Once submitted, our admissions team will contact you to confirm eligibility and request copies of any previous qualifications.

Academic staff review every application and approve eligible candidates for the programme.

Admissions team will notify you if you are accepted onto the course and will request deposit to confirm your place.

Places are limited, so please apply early.




2.5 years (part-time) Online.

Study Hours
3 lectures per week. 3 hours of self-guided study per week.

On-Campus Attendance
No attendance required.


Total Fees €8,500
Per module €850

Non-EU total fees: €16,500

Springboard Fees
Fee €8500
Free for those classified as unemployed.
Fee for employed participants €850 (10% of fees)

Enrolment dates

Contact the college for the next start date.

Post Course Info

Career Opportunities
According to Killian O'Driscoll, NIBRT Director of Projects, there was further good news for the Irish biopharma sector throughout 2018 with the announcement of several major investments. These investments saw the continued diversification of advanced biopharma manufacturing capabilities in Ireland including facilities for Antibody Drug Conjugates (ADCs), cell therapies, iopha-oncology products and the world's largest single use contract manufacturing capacity.

Investments included:
• AbbVie Expands Oncology Capability at the Company's Site in Ballytivnan, Sligo
• MSD is to develop a new biotechnology facility in Dublin, with the expected creation of up to 350 new jobs
• Takeda to invest €25m and create up to 70 new roles in a new facility at their Grange Castle site in Dublin
• WuXi Biologics to Invest €325 million to Build Largest Biomanufacturing Facility Using Single-use Bioreactors in Ireland
• Phibro Animal Health to establish new biotech facility in Sligo, creating up to 150 jobs
• BioMarin Expands its Cork Facility to add Drug Product Filling capability
• MSD to construct a second manufacturing facility at its existing site in Carlow – new investment will create 170 new jobs.


At the BioPharma Ambition conference in February 2018 leading international policy leaders, renowned researchers and senior industry personnel, highlighted how all stakeholders in Ireland must continue to support innovation in discovery, development, manufacturing and healthcare solutions to ensure Ireland builds on its success in establishing a thriving biopharma sector. This programme supports this ambition.

Further Study
Upon successful completion of this programme students may be considered for redirection to a structured Doctorate programmes

More details
  • Qualification letters


  • Qualifications

    Degree - Masters (Level 9 NFQ)

  • Attendance type

    Part time

  • Apply to

    Course provider